Los antihipertensivos no son perjudiciales en la infección de COVID-19

  • Jesús M. Culebras De la Real Academia de Medicina de Valladolid y del IBIOMED, Universidad de León. Miembro de Número y de Honor de la Academia Española de Nutrición y Dietética. Académico Asociado al Instituto de España. AcProfesor Titular de Cirugía. Director, Journal of Negative & No Positive Results. Director Emérito de NUTRICION HOSPITALARIA, España
  • Ángeles Franco-López Jefa de los Servicios de Radiología de los hospitales de Vinalopó y Torrevieja. AcProfesora de Universidad por ANECA, Alicante, España
Palabras clave: COVID-19, pandemia, drogas antihipertensivas

Resumen

-

Descargas

La descarga de datos todavía no está disponible.

Citas

Gallo R, Montagnier L. The discovery of HIV as the cause of AIDS. N Engl J Med. (2003) 349:2283–5. doi: 10.1056/NEJMp038194

John A. Jarcho, Julie R. Ingelfinger, Mary Beth Hamel, Ralph B. D’Agostino, Sr., David P. Harrington. Inhibitors of the Renin–Angiotensin–Aldosterone System and COVID-19. New Engl J Med. May 1, 2020 DOI: 10.1056/NEJMe2012924

Kendrick M. Perhaps 4X more likely to die of COVID-19 if take ACE inhibitors (reduce blood pressure). VitaminDWiki. March 22, 2020 (https://vitamindwiki.com/Perhaps+4X+more+likely+to+die+of+COVID-19+if+take+ACE+inhibitors+%28reduce+blood+pressure%29+-+March+2020. ).

Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin–angiotensin–aldosterone system blockers and the risk of COVID-19. N Engl J Med. DOI: 10.1056/NEJMoa2006923.

Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in COVID- 19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.

Reynolds HR, Adhikari S, Pulgarin C, et al. Renin–angiotensin–aldosterone system inhibitors and risk of COVID- 19. N Engl J Med. DOI: 10.1056/NEJMoa2008975.

Meng J, Xiao G, Zhang J, et al. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 2020;9:757-760.

Zhang P, Zhu L, Cai J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 2020 April 17 (Epub ahead of print).

Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol 2020 April 23 (Epub ahead of print).

Bean DM, Kraljevic Z, Searle T, et al. Treatment with ACE-inhibitors is associated with less severe disease with SARS-COVID-19 infection in a multi-site UK acute hospital trust. MedRxiv. 2020 (https://www.medrxiv.org/content/10.1101/2020.04.07.20056788v1.opens in new tab) (preprint).

Publicado
2020-05-12